According to QuidelOrtho's latest financial reports and stock price the company's current Operating Margin is 2.15%. At the end of 2022 the company had an Operating Margin of 22.53%.
Year | Operating Margin | Change |
---|---|---|
2022 | 22.53% | -57.49% |
2021 | 53.01% | -15.33% |
2020 | 62.61% | 333.9% |
2019 | 14.43% | 18.89% |
2018 | 12.14% | -519.45% |
2017 | -2.89% | -65.78% |
2016 | -8.45% | 78.35% |
2015 | -4.74% | -21.18% |
2014 | -6.01% | -407.21% |
2013 | 1.96% | -59.94% |
2012 | 4.89% | -32.51% |
2011 | 7.24% | -147.11% |
2010 | -15.37% | -148.42% |
2009 | 31.74% | 36.63% |
2008 | 23.23% | 33.65% |
2007 | 17.38% | 22.62% |
2006 | 14.18% | -345.64% |
2005 | -5.77% | -386.72% |
2004 | 2.01% | -81.77% |
2003 | 11.04% | 196.38% |
2002 | 3.72% | -28.45% |
2001 | 5.21% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 14.17% | 559.07% | ๐บ๐ธ USA |
Becton Dickinson BDX | 9.46% | 340.00% | ๐บ๐ธ USA |
Danaher DHR | 26.34% | 1,125.12% | ๐บ๐ธ USA |
PerkinElmer
PKI | 14.13% | 557.21% | ๐บ๐ธ USA |
OraSure Technologies OSUR | -4.25% | -297.67% | ๐บ๐ธ USA |
Meridian Bioscience VIVO | 16.31% | 658.60% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.